Enliven Therapeutics, Inc. (ELVN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Enliven Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.42x | -11.90x | -6.87x | -2.71x | -2.84x | -20.42x |
| P/B Ratio | 1.90x | 3.42x | 2.00x | -1.33x | 0.66x | 4.59x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 28.66x | 19.99x | 10.28x | 8.00x | 19.24x | 14.47x |
| Quick Ratio | 28.66x | 19.99x | 10.28x | 8.00x | 19.24x | 14.47x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | -0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..